PhD Position at the University of Ulster

Non-Equilibrium Chemistry of Multiphase Interfaces (Plasma Group)

Recent progress in plasma-liquid interfaces at atmospheric pressure has opened up a new realm of possibilities that go beyond the traditional wet chemistry. Plasma interactions with liquids can induce a very wide range of non-equilibrium kinetically drive reactions. Coupling such diverse systems is of great importance for many existing application and for new emerging technological opportunities. In particular the synthesis and surface engineering of nanomaterials can largely benefit from future development in plasma-liquid systems.


The objective of this project is to understand the specific plasma-induced chemistries, how these can be controlled and optimized for specific purposes. Therefore, the project will include experimental investigations combined with the development of hybrid plasma-chemical theoretical models that can provide accurate descriptions of the non-equilibrium reactions. While the scientific scope of the project will remain broad, the application focus will be oriented towards nanoscale materials synthesis/processing. The project will also include investigations of reaction kinetics in nano-colloids that can be originated from sources different from plasmas.


The candidate applying for this PhD project should have interest in exploring new horizons for traditional wet chemistry with application in the synthesis/functionalization of nanomaterials and in nanoscale energy harvesting/production. Although the project contains a component of plasma-related work, no prior experience in the specific field of plasmas is required. A predisposition to both experimental and theoretical work is preferred. The research group has strong emphasis on plasma-based synthesis of nanomaterials, and for this reason he/she will be able to develop skills and knowledge that relate to plasma science and technology.


Applications are particularly encouraged from graduates with a Chemistry background.


Further details: Dr D Mariotti (

See also at


30 January 2012